300 completed, 86 unknown, 41 terminated, 37 recruiting. 146 Phase 2, 79 Phase 1, 78 Phase 3, 69 Not applicable, 52 Phase 4.
Follow Leukopenia: new trials by email Literature Review of Leukopenia trials Research Report on Leukopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy ceftazidime, ciprofloxacin, Standard-of-Care Antibiotic Strategy - Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM) | Phase 2 | Not yet recruiting | Zealand University Hospital | 150 | 2027-03-01 | 2026-09-25 |
| A Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Tolerability of Filgrastim Biosimilar and Neupogen Reference Product in Healthy Volunteers Biofilgragen, Neupogen (filgrastim) - Neutropenia (Low White Blood Cell Count) | Phase 1 | Not yet recruiting | BioGeneric Pharma | 50 | 2026-12-15 | 2026-10-20 |
| Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma Acupuncture - Febrile Neutropenia, Sarcoma | Not applicable | Not yet recruiting | Shaare Zedek Medical Center | 60 | 2026-12-01 | 2026-04-29 |
| Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation 8-week Elastic Band Resistance Training Program - Hematologic Malignancies, Hematopoietic Stem Cell Transplantation | Not applicable | Not yet recruiting | Taipei Veterans General Hospital, Taiwan | 86 | 2026-10-12 | 2026-10-14 |
| Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF Breast Cancer, Chemotherapy-Induced Neutropenia | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 132 | 2026-09-30 | 2026-09-08 | |
| Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae Hemato-oncologic Patients, Colonization | Not yet recruiting | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 535 | 2026-09-04 | 2026-09-03 | |
| Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) Levofloxacin, Usual Care - Myeldysplastic Syndrome (MDS), MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) | Phase 2 | Not yet recruiting | University of Manitoba | 75 | 2026-09-01 | 2026-06-29 |
| NAI for Sepsis With Persistent Lymphopenia Nogapendekin alfa inbakicept (NAI), Standard of Care (SOC) - Sepsis, Septic Shock | Phase 2 | Not yet recruiting | ImmunityBio, Inc. | 50 | 2026-07-06 | 2026-05-11 |
| Phase II Study of QLC2519 in Pediatric Solid Tumor Participants Albipagrastim alf - Pediatric Malignant Solid Tumor, Febrile Neutropenia (FN) | Phase 2 | Recruiting | Qilu Pharmaceutical Co., Ltd. | 18 | 2026-06-26 | 2026-07-24 |
| Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia Plasma and DNA sample collection for proteomic and genomic analysis - Febrile Neutropenia | Recruiting | Instituto de Investigación Biomédica de Salamanca | 350 | 2026-06-09 | 2026-06-15 | |
| Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer | Phase 4 | Not yet recruiting | Hospital Universitari Vall d'Hebron Research Institute | 136 | 2026-06-01 | 2026-05-15 |
| Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia Remote temperature monitoring device, Home temperature monitoring by a nurse - Oncopediatrics, Febrile Neutropenia | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de la Réunion | 30 | 2026-05-01 | 2026-01-20 |
| Letermovir vs Valganciclovir in CMV R+ Kidney Transplant Letermovir, Valganciclovir CMV Prophylaxis - CMV Infection, CMV | Phase 4 | Not yet recruiting | Elisabeth Kincaide | 300 | 2026-05-01 | 2026-05-08 |
| Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia Nogapendekin alfa inbakicept (NAI), agenT-797 - Community-Acquired Pneumonia (CAP), Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Withdrawn | ImmunityBio, Inc. | 2026-04-15 | 2026-05-08 | |
| Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS) Nogapendekin Alfa-Inbakicept (NAI), Allogeneic invariant Natural Killer T (iNKT) Cells (AgenT-797) - Acute Respiratory Distress Syndrome, Severe Community-Acquired Pneum | Phase 2 | Withdrawn | ImmunityBio, Inc. | 2026-04-15 | 2026-05-08 | |
| Efficacy of an Empirical Treatment With Amoxicillin-clavulanate (AC) Compared to the Combination Amoxicillin-clavulanate and Ciprofloxacin (AC+C) in the Outpatient Care of Chemotherapy-induced Fever in Adult Haematology Patients. amoxicillin-clavulanate, Amoxicillin-clavulanate ciprofloxacin - C15.378 | Phase 3 | Not yet recruiting | Versailles Hospital | 1526 | 2026-03-01 | 2026-03-19 |
| Analysis of the Therapeutic and Clinical Profile of Cannabinoid Treatments: A Real-World Study Participants are followed while using cannabis-based products (such as CBD or THC oils, extracts, or isolates) as prescribed by their own physicians for therapeutic purposes. - Chronic Pain, Depression Disorders | Enrolling by invitation | Santa Catarina Federal University | 384 | 2026-03-01 | 2026-03-30 | |
| Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients Clinical Stability-Driven Antibiotic Discontinuation Strategy, Standard of Care Antibiotic Duration - Bloodstream Infection, Gram Negative Infections | Not applicable | Recruiting | Valeria Cento | 172 | 2026-02-02 | 2026-09-24 |
| Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children Liposomal Amphotericin B (LAmB) - Thalassemia, Hematopoietic Stem Cell Transplantation | Recruiting | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 30 | 2026-02-01 | 2026-07-24 | |
| the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer Treat Regimen - Leucogen, Ribociclib | Phase 2 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 97 | 2026-01-07 | 2026-09-28 |
Showing 20 of 521. Sign in to see all of them.
Neutropenia (290) · Febrile Neutropenia (143) · Breast Neoplasms (58) · Neoplasms (53) · Fever (44) · Lymphopenia (42) · Wiskott-Aldrich Syndrome (41) · Thrombocytopenia (37) · Infections (35) · Hematologic Neoplasms (33) · Leukemia, Myeloid, Acute (32) · Leukemia (30) · Anemia (24) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (24)
Hemic and Lymphatic Diseases (521) · Leukocyte Disorders (520) · Cytopenia (508) · Hematologic Diseases (500) · Agranulocytosis (407) · Neoplasms (187) · Immune System Diseases (170) · Pathological Conditions, Signs and Symptoms (134) · Neoplasms by Site (130) · Neutropenia (118) · Infections (105) · Immunologic Deficiency Syndromes (100) · Neoplasms by Histologic Type (100) · Pathologic Processes (89)
pegfilgrastim (39) · Filgrastim (36) · Cyclophosphamide (20) · Cefepime (11) · Ciprofloxacin (11) · Meropenem (10) · Vancomycin (10) · Docetaxel (9) · Cyclosporine (8) · Etoposide (8) · Granulocyte Colony-Stimulating Factor (8) · Interleukin-7 (8) · Piperacillin, Tazobactam Drug Combination (8) · pegylated granulocyte colony-stimulating factor (8) · sargramostim (8)
Amgen (16) · National Heart, Lung, and Blood Institute (NHLBI) (15) · National Institute of Allergy and Infectious Diseases (NIAID) (12) · Pfizer (11) · Sandoz (10) · National Cancer Institute (NCI) (8) · Assistance Publique - Hôpitaux de Paris (7) · EVIVE Biotechnology (7) · Revimmune (6) · M.D. Anderson Cancer Center (5) · Merck Sharp & Dohme LLC (5) · Asan Medical Center (4) · Children's Oncology Group (4) · ImmunityBio, Inc. (4) · Insel Gruppe AG, University Hospital Bern (4)
United States (173) · China (50) · France (49) · South Korea (22) · Canada (21) · Germany (20) · Italy (19) · Spain (16) · Australia (15) · Israel (15) · Netherlands (14) · Russia (14) · Switzerland (14) · United Kingdom (14) · Belgium (13)
Danielle M Townsley, M.D. (4) · Thomas J. Walsh, MD (4) · Irini Sereti, M.D. (3) · Paul Szabolcs, MD (3) · Aaron Cumpston, PharmD, BCOP (2) · Binghe XU, MD (2) · Christa Koenig, MD (2) · Cynthia E Dunbar, M.D. (2) · David H McDermott, M.D. (2) · Elizabeth K Garabedian, R.N. (2)
PMID 39903535, PMID 29958797, PMID 32031570, PMID 32171076, PMID 29515037, PMID 29674506, PMID 35075289, PMID 19549917, PMID 23053510, PMID 23317527, PMID 28637287, PMID 29419434, PMID 30900158, PMID 33789616, PMID 34724566, PMID 36818468, PMID 38446574, PMID 42777242, PMID 10091805, PMID 10561360, PMID 10737767, PMID 12010786, PMID 12084168, PMID 12411295, PMID 12610500, PMID 12628464, PMID 12660125, PMID 12759326, PMID 12816983, PMID 14557216, PMID 14615453, PMID 15459300, PMID 15503313, PMID 15569976, PMID 15629410, PMID 15718314, PMID 15761020, PMID 15770833, PMID 15806544, PMID 15814645, PMID 15841203, PMID 15905493, PMID 16096770, PMID 16163382, PMID 16249702, PMID 16382125, PMID 16557261, PMID 16699374, PMID 16932345, PMID 17008536
2014 (4), 2018 (3), 2009 (2), 2016 (2), 2023 (2), U10CA095861 (2), 2005 (1), 2025 (1), P01CA075606 (1), P30AI060354 (1), P30CA012197 (1), P30CA015083 (1), P30CA015704 (1), P30CA016086 (1), P30CA016672 (1)